Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) - Test2 - elhamkhani - TriplyDB

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

http://www.wikidata.org/entity/Q24193707

about

Souvenaid for Alzheimer's disease 18F PET ligands for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected Dementia: timely diagnosis and early intervention Peptides from adipose tissue in mental disorders Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research.Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker Environmental risk factors for dementia: a systematic review.A correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).The usual suspects: why techno-fixing dementia is flawed.The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Validation of olfactory deficit as a biomarker of Alzheimer disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.Are methodological quality and completeness of reporting associated with citation-based measures of publication impact? A secondary analysis of a systematic review of dementia biomarker studies.Is late-onset Alzheimer's disease really a disease of midlife?Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy Studies.

P2860

Q24188326-611ED778-7909-4FE0-8C95-7F641293A18C Q26472008-39503D25-D49D-454D-BB3A-92B4241E86D8 Q26773443-2EF4252D-3444-4A0F-9634-C82652F09E6F Q27007436-794D678D-5A0A-47BA-BBA7-A1AFBEEC7F3A Q28082444-AA1DC7BE-D564-4C9B-AACA-FCC6D47A22C5 Q34761266-D9EA55CE-B01A-4FDC-BDB8-D82D72D31E0F Q35189470-467ACA9D-CD01-4A7B-9252-6A7DCFC44B97 Q35888210-CDAE9366-0758-47A1-AA05-C4AB1F544B58 Q36082829-BAE12A1A-2C47-418A-8D4C-CF81DC4EBACB Q36160728-831ABA6A-C0FC-4FE1-896B-21F2DD30A49A Q36209423-AD8D7C15-82A2-4FA7-A681-1BB1720DF62F Q37708297-758DD5A7-F08D-484C-B8A2-AB60DAA47749 Q38644393-02682CE3-4BDD-48AA-83B3-38D28102779E Q38741683-FF97A866-0ADB-49D7-B59C-6A6DF8434B2E Q38796871-1C128BC9-ED92-4B2F-B2C7-F018CC241E95 Q42627792-2F87009F-2868-4847-BD5A-FA460147BC9B Q42683308-3C0CBD6C-6D0A-42FA-8D08-A3DEE06C7CCE Q47200597-1441804B-89BB-4C2E-A3E2-1F7543AF44D9 Q47209544-4F1357B2-2902-4B29-8BC3-738E0D346FEE Q47209556-A58F5936-8177-4884-ACFB-162CEEC01AE9 Q47209563-FA1206AB-A107-43C4-825A-69A9E6AADEDD Q47428952-06069A94-D5FC-4FAD-82EB-9B68344BBDC5 Q47587631-34A6D545-3E16-4353-A4A3-96DC771BDAED Q50034469-BAD982A3-456A-4C6A-9163-BE7D5CC6500F Q50635583-FD9411C0-53D7-43F4-B694-AACF5EF624A2 Q53835370-9F044865-6248-4CF5-B4C9-495D1D96B6CC Q54943031-10FB7AE6-66D2-4E0A-AEEA-D26E4BFCFD25 Q55025120-1C1E7D34-3021-4D56-BFC9-CD35D94A3C43

P2860

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

http://www.wikidata.org/entity/Q24193707

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@ast

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en-gb

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@nl

type

label

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@ast

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en-gb

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@nl

prefLabel

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@ast

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en-gb

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@nl

P1433

Q24193707-588A6E0B-DF35-4A41-A9AF-6480F6AA16B5

P1476

Q24193707-AD8B61F6-468F-4CDA-A2C9-FAA3D54E47BA

P2093

Q24193707-0E519A1F-890E-4B08-A6A3-C72DD2E2147A

Q24193707-911AF54E-59D8-4FFB-9513-7288724C89E0

Q24193707-D4943796-2752-4A60-8702-1E4E74E0D893

Q24193707-D792B251-3F50-4471-9197-A257E8FC7CAC

Q24193707-F38D87E0-A845-4F98-A642-94BC7C20A14A

Q24193707-F8583A3F-26C7-462D-A9BE-D3562D19CF7D

P2860

Q24193707-0B5B8D48-A001-48DE-B584-B9485609E332

Q24193707-0BE2A60C-E3E7-4C05-A98A-6C337B048DB6

Q24193707-0BECB54A-8EB0-44AA-8F82-878059D1A631

Q24193707-1103489E-E910-4D8B-BF55-9A888405E245

Q24193707-1733FA5C-F5B9-4EBD-B7BC-005D011B41D8

Q24193707-1F873A61-3838-41B6-A905-D179965642DB

Q24193707-1FA408AA-7114-4BE7-B466-B5E1D3454BCB

Q24193707-228A6343-AA50-4900-990E-B0F07D41E5D5

Q24193707-2C8E8C4B-EB56-4811-90B9-CE0D68339EEE

Q24193707-2DF2B72F-31DD-4AEA-86CB-48E0F12579A2

P304

Q24193707-63B237B1-2B1C-4071-A794-7F8BFB6262ED

P31

Q24193707-693A48B8-2B31-4F2C-8CD9-53A1FB5EE29A

Q24193707-90a00cac-964b-44ef-a5cd-b9ce01dafbe8

P3181

Q24193707-46D6D1CE-DE04-4FED-A051-B8CA94C6495F

P356

Q24193707-96F41FF1-0FA9-40BD-B72F-17655AB4F014

P433

Q24193707-9797B53C-819A-4A30-86E7-8216BD6D7540

P50

Q24193707-3672E5CB-4CFB-4222-B67B-F62549F694B0

P577

Q24193707-48631CAD-EF62-4A81-A768-343765B29B9C

P698

Q24193707-20C0F88E-E79A-4BB0-9A8E-7159B5ABBEF2

P921

Q24193707-1787A3B3-216B-4E3A-A9E1-2ED4965B846D

Q24193707-23705899-0AFF-4C72-812B-988DF0CCD761

Q24193707-4AE74F39-2DE0-4401-8380-9A54E394CCDA

P932

Q24193707-5746C0E2-09EB-44F2-83E7-1172178139D5

P3181

P356

14651858.CD008782.PUB4

P1433

Cochrane Database of Systematic Reviews

P1476

Plasma and cerebrospinal fluid ...... ild cognitive impairment (MCI)

@en

P2093

Anna H Noel-Storr

http://www.w3.org/2001/XMLSchema#string

Craig Ritchie

http://www.w3.org/2001/XMLSchema#string

Leon Flicker

http://www.w3.org/2001/XMLSchema#string

Nadja Smailagic

http://www.w3.org/2001/XMLSchema#string

Rupert McShane

http://www.w3.org/2001/XMLSchema#string

Sam E Mason

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

Reliability and Validity of NINCDS-ADRDA Criteria for Alzheimer's Disease

Global prevalence of dementia: a Delphi consensus study

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Mild cognitive impairment: clinical characterization and outcome

Neuropathologic features of amnestic mild cognitive impairment

Alzheimer's disease: the amyloid cascade hypothesis

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

P304

CD008782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3033795

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD008782.PUB4

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P50

Yemisi Takwoingi

P577

2014-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24913723

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

6465069

http://www.w3.org/2001/XMLSchema#string